198 Participants Needed

Exercise + Psychotherapy for Opioid Use Disorder

(EXPO-R33 Trial)

Recruiting at 1 trial location
NL
Overseen ByNora L. Nock, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Case Western Reserve University
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This work will involve conducting a randomized trial that will evaluate preliminary efficacy of "assisted" rate cycling, voluntary rate cycling and psychotherapy for pain individually and in combination as adjunctive treatments on cravings (primary outcome) in adults with an opioid use disorder. The investigators will also evaluate the effects of "assisted" rate cycling, voluntary rate cycling and I-STOP on secondary outcomes including depression, anxiety and sleep.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of this treatment for opioid use disorder?

Research shows that exercise can improve brain health, sleep, and overall quality of life for people with opioid use disorder, and it may help reduce anxiety, depression, and cravings. Additionally, studies suggest that exercise can lead to longer periods of abstinence in substance use disorder treatments.12345

Is exercise and psychotherapy safe for people with opioid use disorder?

Exercise is generally considered safe for individuals with opioid use disorder and may improve mood, reduce anxiety and depression, and enhance overall quality of life. Participants in studies have found exercise to be an acceptable and feasible part of their treatment.13678

How does the Exercise + Psychotherapy treatment for Opioid Use Disorder differ from other treatments?

This treatment is unique because it combines exercise with psychotherapy, which may improve brain health, sleep, and overall quality of life while reducing anxiety, depression, and pain. Unlike standard drug treatments, this approach uses physical activity as an adjunct therapy to enhance the benefits of traditional opioid use disorder treatments.13479

Research Team

NL

Nora L Nock, PhD

Principal Investigator

Case Western Reserve University

Eligibility Criteria

Adults aged 18-65 with an Opioid Use Disorder or Poly-substance Drug Use including opioids, enrolled in a residential drug treatment program. Participants must have chronic non-cancer pain and be medically cleared to exercise by the treatment center's staff.

Inclusion Criteria

Diagnosed with an Opioid Use Disorder (OUD; ICD-10 F11.20) or a Poly-substance Drug Use that includes an opioid component (ICD-10,F19.xx)
Approved to exercise in the study by the drug treatment center (Medical Director, physician or other relevant clinical staff or primary care physician (PCP))
I am between 18 and 65 years old.
See 2 more

Exclusion Criteria

Any substantive contraindications to exercise

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 'assisted' rate cycling, voluntary rate cycling, and psychotherapy for pain individually and in combination as adjunctive treatments

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Exercise
  • Psychotherapy
Trial OverviewThe trial is testing how 'assisted' rate cycling, voluntary rate cycling, and psychotherapy for pain (I-STOP) affect cravings in opioid users. It also looks at their impact on depression, anxiety, and sleep as secondary outcomes.
Participant Groups
6Treatment groups
Experimental Treatment
Active Control
Group I: Voluntary Exercise and No I-STOPExperimental Treatment1 Intervention
Participants randomized to "Voluntary Exercise" will exercise on a standard stationary bike where they will pedal at their voluntary rates. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group II: Voluntary Exercise and I-STOPExperimental Treatment2 Interventions
Participants randomized to "Voluntary Exercise" will exercise on a standard stationary bike where they will pedal at their voluntary rates. Participants who are randomized to receive I-STOP will receive the "Self-regulation Treatment for Opioid addiction and Pain" (STOP) program modified for inpatients/residential drug treatment (I-STOP).
Group III: No Exercise and I-STOPExperimental Treatment1 Intervention
Participants randomized to receive "No Exercise" will not receive structured "assisted" or voluntary rate cycling exercise. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group IV: Assisted Exercise and No I-STOPExperimental Treatment1 Intervention
Participants randomized to "Assisted Exercise" will exercise on a special bike that assists them to pedal faster than they do voluntarily on their own ("assisted" exercise bike). Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).
Group V: Assisted Exercise and I-STOPExperimental Treatment2 Interventions
Participants randomized to "Assisted Exercise" will exercise on a special bike that assists them to pedal faster than they do voluntarily on their own ("assisted" exercise bike). Participants who are randomized to receive I-STOP will receive the "Self-regulation Treatment for Opioid addiction and Pain" (STOP) program modified for inpatients/residential drug treatment (I-STOP).
Group VI: No Exercise and No I-STOPActive Control1 Intervention
Participants randomized to receive "No Exercise" will not receive structured "assisted" or voluntary rate cycling exercise. Participants randomized to "No I-STOP" will not receive the psychotherapy for pain and addiction but will receive their standard behavioral treatment as usual (TAU).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Case Western Reserve University

Lead Sponsor

Trials
314
Recruited
236,000+

University of Colorado, Denver

Collaborator

Trials
1,842
Recruited
3,028,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

Findings from Research

Exercise interventions for individuals with opioid use disorder (OUD) have shown positive effects on immune function, pain reduction, cravings, anxiety, depression, mood, and overall quality of life, based on a review of 13 studies.
While exercise is considered an acceptable and feasible adjunct treatment for OUD, most studies involved small sample sizes, highlighting the need for further research with larger groups to confirm these benefits.
Physical activity and exercise interventions for individuals with opioid use disorder: a scoping review.Shreffler, J., Genova, G., Huecker, M.[2022]
A pilot study involving 16 drug-dependent patients showed that a 12-week moderate-intensity aerobic exercise program is feasible and can be integrated into substance abuse treatment.
Participants who attended at least 75% of the exercise sessions had significantly better outcomes in terms of abstinence from drugs and alcohol, along with improved cardiorespiratory fitness, suggesting that exercise may enhance recovery efforts.
A Pilot Study of Aerobic Exercise as an Adjunctive Treatment for Drug Dependence.Brown, RA., Abrantes, AM., Read, JP., et al.[2022]
Physical activity interventions for patients undergoing opioid substitution therapy have been shown to improve physical fitness and reduce substance use, based on a systematic review of 10 studies.
Despite the positive findings, the majority of studies in this area lack high methodological quality and sufficient power, indicating a need for more robust clinical trials to confirm these benefits.
The Role of Physical Activity in Opioid Substitution Therapy: A Systematic Review of Interventional and Observational Studies.Alpers, SE., Furulund, E., Pallesen, S., et al.[2022]

References

Physical activity and exercise interventions for individuals with opioid use disorder: a scoping review. [2022]
A Pilot Study of Aerobic Exercise as an Adjunctive Treatment for Drug Dependence. [2022]
The Role of Physical Activity in Opioid Substitution Therapy: A Systematic Review of Interventional and Observational Studies. [2022]
Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders. [2022]
EXERCISE PREFERENCES OF PATIENTS IN SUBSTANCE ABUSE TREATMENT. [2022]
Exercise training - A beneficial intervention in the treatment of alcohol use disorders? [2022]
Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study. [2023]
Evaluation of the Effects of High Intensity Interval Training on Cytokine Levels and Clinical Course in Treatment of Opioid Use Disorder. [2022]
Exercise as an adjunct treatment for opiate agonist treatment: review of the current research and implementation strategies. [2021]